Cart
sales@molnova.com
Xl-281
CAS No. 870603-16-0
Xl-281( —— )
Catalog No. M36246 CAS No. 870603-16-0
Xl-281 (BMS-908662) is a BRAF inhibitor with anti-tumor activity for the study of colorectal cancer and melanoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXl-281
-
NoteResearch use only, not for human use.
-
Brief DescriptionXl-281 (BMS-908662) is a BRAF inhibitor with anti-tumor activity for the study of colorectal cancer and melanoma.
-
DescriptionXl-281 (BMS-908662) is a BRAF inhibitor with anti-tumor activity for the study of colorectal cancer and melanoma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorRaf
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870603-16-0
-
Formula Weight462.89
-
Molecular FormulaC24H19ClN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC)NC1=NC=2C=CC(=CC2N1)C3(O)C=4C=CC=CC4C(=O)N3C5=CC(Cl)=CC=C5C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Exarafenib
Exarafenib (RAF/KIN_2787) is a potent, orally available pan-RAF inhibitor with antitumor activity that acts by inhibiting downstream MAPK pathway signaling. It is used in cancer research.
-
MCP110
MCP110 is a potent Ras/Raf-1 interaction inhibitor.
-
PLX-7904
A potent and selective BRaf inhibitor with IC50 of 5 nM against BRaf V600E in mutant RAS expressing cells.
